Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Geisbert

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|August 27, 2005
Therapy and prophylaxis of Ebola virus infectionsHeinz Feldmann, Steven M Jones, Hans-Joachim Schnittler, et al.
Journal of Virology|March 22, 2002
Human T-lymphotropic virus type 1 oncoprotein tax promotes S-phase entry but blocks mitosisMin-Hui Liang, Thomas Geisbert, Yao Yao, et al.
Plos Neglected Tropical Diseases|April 18, 2015
A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa virusesDavid Safronetz, Chad Mire, Kyle Rosenke, et al.
Journal of Virology|January 7, 2021
Transcriptional Analysis of Lymphoid Tissues from Infected Nonhuman Primates Reveals the Basis for Attenuation and Immunogenicity of an Ebola Virus Encoding a Mutant VP35 ProteinAmanda Pinski, Courtney Woolsey, Allen Jankeel, et al.
The Journal of Clinical Investigation|March 31, 2026
Human antibody targeting Crimean-Congo hemorrhagic fever virus glycoprotein 38 protects mice against heterologous virus challengeNathaniel S Chapman, Viktoriya Borisevich, Nurgun Kose, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Opinion in Investigational Drugs (London, England : 2000)|August 27, 2005
Therapy and prophylaxis of Ebola virus infectionsHeinz Feldmann, Steven M Jones, Hans-Joachim Schnittler, et al.
Journal of Virology|March 22, 2002
Human T-lymphotropic virus type 1 oncoprotein tax promotes S-phase entry but blocks mitosisMin-Hui Liang, Thomas Geisbert, Yao Yao, et al.
Plos Neglected Tropical Diseases|April 18, 2015
A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa virusesDavid Safronetz, Chad Mire, Kyle Rosenke, et al.
Journal of Virology|January 7, 2021
Transcriptional Analysis of Lymphoid Tissues from Infected Nonhuman Primates Reveals the Basis for Attenuation and Immunogenicity of an Ebola Virus Encoding a Mutant VP35 ProteinAmanda Pinski, Courtney Woolsey, Allen Jankeel, et al.
The Journal of Clinical Investigation|March 31, 2026
Human antibody targeting Crimean-Congo hemorrhagic fever virus glycoprotein 38 protects mice against heterologous virus challengeNathaniel S Chapman, Viktoriya Borisevich, Nurgun Kose, et al.
Pageof 1